According to a filing from RiskOn, the company is in danger of being delisted due to its share price. The company has remained below the $1 minimum bid price for 31 consecutive trading days.
RiskOn International says it will be monitoring its closing bid price as it determines what to do about the delisting notice. If needed, the company says it will take action to get the price of ROI stock back up above the $1 minimum required for listing on the Nasdaq.
What This Means for ROI Stock
Investors don’t have to worry about this delisting notice having an immediate effect on ROI stock. The notice gives the company until April 30, 2024 to get the price back above the $1 minimum. The company may also be eligible for an 180-day extension to regain compliance after that deadline.
The delisting notice has sent ROI stock on a wild ride today. During pre-market trading, the company’s shares were falling. However, the stock recovered from that and was gaining before the opening bell. As of this writing, ROI stock is up 8.7%.
Investors who are looking for more of the most recent stock market news will want to keep reading!
We’re offering up all of the hottest stock market news traders need to know about on Monday! That includes everything happening with shares of NexImmune (NASDAQ:NEXI) stock, OrganiGram (NASDAQ:OGI) stock and Carbon Revolution (NASDAQ:CREV) stock today. You can read up on all of these matters at the following links!
More Stock Market News for Monday
- Why Is NexImmune (NEXI) Stock Down 10% Today?
- Why Is OrganiGram (OGI) Stock Up 35% Today?
- Why Is Carbon Revolution (CREV) Stock Up 362% Today?
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.